Number of the records: 1  

ipilimumab

  1. Record numberd000074324
    Date06.06.2025
    TypeM - MESH
    Topical termipilimumab
    Other termSlovak (Pseudonym) anti-CTLA-4 MAb ipilimumab
    Slovak (Pseudonym) MDX 010
    Slovak (Pseudonym) MDX-CTLA-4
    See also(Later heading) antigén CTLA-4
    (Skutočné meno) antineoplastiká imunologické
    (Skutočné meno) inhibítory imunitných kontrolných bodov
    (Skutočné meno) antigén CTLA-4
    UDCD12.776.124.486.485.114.224.060.798D12.776.124.790.651.114.224.060.798D12.776.377.715.548.114.224.200.798
    NoteAn anti-CTLA-4 ANTIGEN monoclonal antibody initially indicated for the treatment of certain types of metastatic MELANOMA. Its mode of actions may include blocking of CTLA-4 mediated inhibition of CYTOTOXIC T LYMPHOCYTES, allowing for more efficient destruction of target tumor cells.
    subject heading

    subject heading

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all